Home > PE Ratio > TRIDENT LIFELINE

TRIDENT LIFELINE
PE (Price/Earnings) Ratio

The Current P/E Ratio of TRIDENT LIFELINE is 28.40.

Share Price ₹150.5May 31,2024
Market Cap ₹173.1 Cr
Earnings-TTM₹6.1 CrTTM-Consolidated Results
Price/Earnings28.40xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for TRIDENT LIFELINE
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of TRIDENT LIFELINE

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of TRIDENT LIFELINE is calculated as :

Current Market Cap [ ₹173.1 Cr] as on May 31,2024

(/) Earnings [ ₹6.1 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 28.40x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for TRIDENT LIFELINE , the investors are currently willing to pay 28.40 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TRIDENT LIFELINE !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of TRIDENT LIFELINE over the last five years.

Historical PE (Price/Earnings) ratio chart of TRIDENT LIFELINE


PE Ratio Performance Analysis for TRIDENT LIFELINE

- TRIDENT LIFELINE 's latest p/e ratio is 28.40x.

- TRIDENT LIFELINE 's p/e ratio for fiscal years ending Mar2023 to Mar2022 averaged 15.21x.

- TRIDENT LIFELINE 's operated at median p/e ratio of 30.41x from fiscal years ending March 2018 to 2022.

- Looking back at the last 2 fiscal years, TRIDENT LIFELINE 's p/e ratio peaked in Mar2023 at 30.41x.

- TRIDENT LIFELINE 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does TRIDENT LIFELINE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
TRIDENT LIFELINE 6.1028.40173.1
SUN PHARMACEUTICAL INDUSTRIES LTD9,648.4436.31350,339.0
CIPLA LTD4,155.3128.14116,930.0
DR REDDYS LABORATORIES LTD5,563.2017.3596,546.9
ZYDUS LIFESCIENCES LTD3,831.4026.28100,694.0
DIVIS LABORATORIES LTD1,600.0071.51114,416.0
MANKIND PHARMA LTD1,926.5544.6385,978.3
TORRENT PHARMACEUTICALS LTD1,656.0055.1191,258.4
LUPIN LTD1,935.5737.4072,388.0
AUROBINDO PHARMA LTD3,186.1321.8369,550.9
ABBOTT INDIA LTD1,201.2245.7754,984.6

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TRIDENT LIFELINE 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.35x
Max industry PE 71.51x
Median industry PE 36.31x
Average industry PE 37.52x



You may also like the below Video Courses